Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment

European Journal of Medicinal Chemistry
2018.0

Abstract

Cannabinoid type 2 (CB2) receptor continues to emerge as a promising drug target for many diseases and conditions. New tools for studying CB2 receptor are required to further inform how this receptor functions in healthy and diseased states. The alkyl indole scaffold is a well-recognised ligand for cannabinoid receptors, and in this study the indole C5-7 positions were explored for linker and fluorophore attachment. A new high affinity, CB2 receptor selective inverse agonist was identified (16b) along with a general trend of C5-substituted indoles acting as agonists versus C7-substituted indoles acting as inverse agonists. The indole C7 position was found to be the most tolerant to linker extension and resulted in a high affinity inverse agonist with a medium length linker (19). Although a high affinity fluorescent ligand for CB2 receptor was not identified in this study, the indole C7 position shows great promise for fluorophore or probe attachment.

Knowledge Graph

Similar Paper

Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment
European Journal of Medicinal Chemistry 2018.0
Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: Design, synthesis, structure–activity relationships, physicochemical properties and biological activity
European Journal of Medicinal Chemistry 2011.0
Indol-3-yl-tetramethylcyclopropyl Ketones: Effects of Indole Ring Substitution on CB<sub>2</sub> Cannabinoid Receptor Activity
Journal of Medicinal Chemistry 2008.0
Indol-3-ylcycloalkyl Ketones: Effects of N1 Substituted Indole Side Chain Variations on CB<sub>2</sub> Cannabinoid Receptor Activity
Journal of Medicinal Chemistry 2010.0
Evaluation of (Z)-2-((1-benzyl-1H-indol-3-yl)methylene)-quinuclidin-3-one analogues as novel, high affinity ligands for CB1 and CB2 cannabinoid receptors
Bioorganic &amp; Medicinal Chemistry Letters 2013.0
Development of fluorinated CB2 receptor agonists for PET studies
Bioorganic &amp; Medicinal Chemistry 2013.0
Rational Design and Synthesis of an Orally Active Indolopyridone as a Novel Conformationally Constrained Cannabinoid Ligand Possessing Antiinflammatory Properties
Journal of Medicinal Chemistry 2003.0
C-3 Amido-Indole cannabinoid receptor modulators
Bioorganic &amp; Medicinal Chemistry Letters 2002.0
New class of potent ligands for the human peripheral cannabinoid receptor
Bioorganic &amp; Medicinal Chemistry Letters 1996.0
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking
European Journal of Medicinal Chemistry 2017.0